A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients - Related Studies

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

This study has been completed.

Study NCT00002399. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Candidiasis, Oral
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Candidiasis
		Infection

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mouth Diseases
		Mycoses
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Stomatognathic Diseases
		Virus Diseases

4	Interventions listed in this trial
		Posaconazole
		Fluconazole

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antibiotics, Antifungal
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses
		Trypanocidal Agents

6	Sponsors listed in this trial
		Schering-Plough